{"transactions":[{"id":686587,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:12:22.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":29849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":29849},"source":{"system":"sec-edgar","filing":"0001539937-26-000012","document":"wk-form4_1786741940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000012/wk-form4_1786741940.xml","form_type":"4"}},{"id":686586,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-08-14T21:12:22.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":12642,"price":46.57,"value":588737.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":1258351,"source":{"system":"sec-edgar","filing":"0001539937-26-000012","document":"wk-form4_1786741940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000012/wk-form4_1786741940.xml","form_type":"4"}},{"id":686585,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-08-14T21:12:22.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":29849,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1270993,"source":{"system":"sec-edgar","filing":"0001539937-26-000012","document":"wk-form4_1786741940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000012/wk-form4_1786741940.xml","form_type":"4"}},{"id":699771,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:06:38.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":29849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":29849,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":29849},"source":{"system":"sec-edgar","filing":"0001539937-26-000010","document":"wk-form4_1785531995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000010/wk-form4_1785531995.xml","form_type":"4"}},{"id":730437,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T21:18:09.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":73500,"source":{"system":"sec-edgar","filing":"0001104659-26-076477","document":"tm2618497-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926076477/tm2618497-4_4seq1.xml","form_type":"4"}},{"id":841303,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":120,"price":51.75,"value":6210.0,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."}],"balance_after":958100,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841302,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":10742,"price":51,"value":547842.0,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.63 to $51.54. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":958220,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841301,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":24138,"price":50.09,"value":1209072.42,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to a 10b5-1 trading plan adopted December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.63 to $50.62. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":968962,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841300,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"other","planned":true,"acquired":false,"shares":12500,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is filing this Form 4 to reflect the fact that 12,500 shares were transferred from the KBT Trust to the Reporting Person on March 13, 2026 without consideration and are now owned directly."}],"balance_after":993100,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":841299,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-16T20:08:19.000Z","date":"2026-03-13","kind":"other","planned":true,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is filing this Form 4 to reflect the fact that 12,500 shares were transferred from the KBT Trust to the Reporting Person on March 13, 2026 without consideration and are now owned directly."}],"balance_after":1241144,"source":{"system":"sec-edgar","filing":"0001539937-26-000008","document":"wk-form4_1773691696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000008/wk-form4_1773691696.xml","form_type":"4"}},{"id":850497,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-03-10T20:13:50.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001539937-26-000006","document":"wk-form4_1773173627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000006/wk-form4_1773173627.xml","form_type":"4"}},{"id":850496,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:50.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":16574,"price":54.73,"value":907095.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":1228644,"source":{"system":"sec-edgar","filing":"0001539937-26-000006","document":"wk-form4_1773173627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000006/wk-form4_1773173627.xml","form_type":"4"}},{"id":850495,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2026-03-10T20:13:50.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1245218,"source":{"system":"sec-edgar","filing":"0001539937-26-000006","document":"wk-form4_1773173627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000006/wk-form4_1773173627.xml","form_type":"4"}},{"id":865761,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2026-03-03T21:12:06.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":38640,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001539937-26-000004","document":"wk-form4_1772572321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000004/wk-form4_1772572321.xml","form_type":"4"}},{"id":890354,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-20T21:46:10.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":341610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 18, 2027."}],"balance_after":341610,"derivative":{"exercise_price":50.2,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":341610},"source":{"system":"sec-edgar","filing":"0001539937-26-000002","document":"wk-form4_1771623966.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993726000002/wk-form4_1771623966.xml","form_type":"4"}},{"id":1019987,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-10T21:33:23.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":false,"shares":81250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in four equal installments beginning on February 24, 2018"}],"balance_after":0,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":81250},"source":{"system":"sec-edgar","filing":"0001628280-25-044830","document":"wk-form4_1760132000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025044830/wk-form4_1760132000.xml","form_type":"4"}},{"id":1019986,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-10T21:33:23.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":1529,"price":51.46,"value":78682.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.14 to $51.76. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1206578,"source":{"system":"sec-edgar","filing":"0001628280-25-044830","document":"wk-form4_1760132000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025044830/wk-form4_1760132000.xml","form_type":"4"}},{"id":1019985,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-10T21:33:23.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":58371,"price":50.55,"value":2950654.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.11 to $51.09. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1208107,"source":{"system":"sec-edgar","filing":"0001628280-25-044830","document":"wk-form4_1760132000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025044830/wk-form4_1760132000.xml","form_type":"4"}},{"id":1019984,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-10T21:33:23.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":true,"shares":81250,"price":25.3,"value":2055625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1266478,"source":{"system":"sec-edgar","filing":"0001628280-25-044830","document":"wk-form4_1760132000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025044830/wk-form4_1760132000.xml","form_type":"4"}},{"id":1022154,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:03.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.37,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":6124},"source":{"system":"sec-edgar","filing":"0001193125-25-233528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233528/ownership.xml","form_type":"4"}},{"id":1022153,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:03.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":4.53,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001193125-25-233528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233528/ownership.xml","form_type":"4"}},{"id":1022152,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:03.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":4.11,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":19750},"source":{"system":"sec-edgar","filing":"0001193125-25-233528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233528/ownership.xml","form_type":"4"}},{"id":1022151,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-07T16:30:03.000Z","date":"2025-10-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option."}],"balance_after":0,"derivative":{"exercise_price":3.85,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-25-233528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233528/ownership.xml","form_type":"4"}},{"id":1022150,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T16:30:03.000Z","date":"2025-10-07","kind":"other","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the \"Merger Agreement\"), by and among the Issuer, MannKind Corporation (\"Parent\") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's common stock (\"Common Stock\") on October 7, 2025. Tendering stockholders received per share consideration of $5.35 in cash, without interest, subject to any applicable withholding taxes, plus one non-tradable contingent value right (\"CVR\"), representing the right to receive certain contingent payments of up to an aggregate amount of $1.00 per CVR in cash,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) without interest, subject to any applicable withholding taxes, upon the achievement of certain regulatory and net sales milestones on or prior to the applicable milestone outside dates. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\", and the effective time of the Merger, the \"Effective Time\"), with the Issuer continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-233528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000119312525233528/ownership.xml","form_type":"4"}},{"id":1024252,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Units","published_at":"2025-10-03T20:19:46.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":false,"shares":19320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":19320},"source":{"system":"sec-edgar","filing":"0001539937-25-000030","document":"wk-form4_1759522783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000030/wk-form4_1759522783.xml","form_type":"4"}},{"id":1024251,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2025-10-03T20:19:46.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on April 30, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on April 30, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001539937-25-000030","document":"wk-form4_1759522783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000030/wk-form4_1759522783.xml","form_type":"4"}},{"id":1024250,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:19:46.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":7529,"price":46.21,"value":347915.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":1185228,"source":{"system":"sec-edgar","filing":"0001539937-25-000030","document":"wk-form4_1759522783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000030/wk-form4_1759522783.xml","form_type":"4"}},{"id":1024249,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:19:46.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":true,"shares":19320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024."}],"balance_after":1192757,"source":{"system":"sec-edgar","filing":"0001539937-25-000030","document":"wk-form4_1759522783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000030/wk-form4_1759522783.xml","form_type":"4"}},{"id":1024248,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:19:46.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":7796,"price":46.21,"value":360253.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":1173437,"source":{"system":"sec-edgar","filing":"0001539937-25-000030","document":"wk-form4_1759522783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000030/wk-form4_1759522783.xml","form_type":"4"}},{"id":1024247,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:19:46.000Z","date":"2025-10-02","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 19, 2021."}],"balance_after":1181233,"source":{"system":"sec-edgar","filing":"0001539937-25-000030","document":"wk-form4_1759522783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000030/wk-form4_1759522783.xml","form_type":"4"}},{"id":1024246,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-03T20:18:34.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":false,"shares":2267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal installments beginning on February 24, 2018"}],"balance_after":81250,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":2267},"source":{"system":"sec-edgar","filing":"0001539937-25-000028","document":"wk-form4_1759522711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000028/wk-form4_1759522711.xml","form_type":"4"}},{"id":1024245,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:18:34.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":1904,"price":48.06,"value":91506.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.08. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1161233,"source":{"system":"sec-edgar","filing":"0001539937-25-000028","document":"wk-form4_1759522711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000028/wk-form4_1759522711.xml","form_type":"4"}},{"id":1024244,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:18:34.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":true,"shares":2267,"price":25.3,"value":57355.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1163137,"source":{"system":"sec-edgar","filing":"0001539937-25-000028","document":"wk-form4_1759522711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000028/wk-form4_1759522711.xml","form_type":"4"}},{"id":1026614,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-02T20:02:42.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":false,"shares":53785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal installments beginning on February 24, 2018"}],"balance_after":83517,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":53785},"source":{"system":"sec-edgar","filing":"0001539937-25-000026","document":"wk-form4_1759435359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000026/wk-form4_1759435359.xml","form_type":"4"}},{"id":1026613,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-02T20:02:42.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":40173,"price":48.07,"value":1931116.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.25. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1160870,"source":{"system":"sec-edgar","filing":"0001539937-25-000026","document":"wk-form4_1759435359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000026/wk-form4_1759435359.xml","form_type":"4"}},{"id":1026612,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-02T20:02:42.000Z","date":"2025-10-01","kind":"exercise","planned":true,"acquired":true,"shares":53785,"price":25.3,"value":1360760.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1201043,"source":{"system":"sec-edgar","filing":"0001539937-25-000026","document":"wk-form4_1759435359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000026/wk-form4_1759435359.xml","form_type":"4"}},{"id":1029109,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-01T20:20:32.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":false,"shares":11510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal installments beginning on February 24, 2018"}],"balance_after":137302,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":11510},"source":{"system":"sec-edgar","filing":"0001539937-25-000024","document":"wk-form4_1759350029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000024/wk-form4_1759350029.xml","form_type":"4"}},{"id":1029108,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-01T20:20:32.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":8588,"price":48.25,"value":414371.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.44. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1147258,"source":{"system":"sec-edgar","filing":"0001539937-25-000024","document":"wk-form4_1759350029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000024/wk-form4_1759350029.xml","form_type":"4"}},{"id":1029107,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-10-01T20:20:32.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":true,"shares":11510,"price":25.3,"value":291203.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1155846,"source":{"system":"sec-edgar","filing":"0001539937-25-000024","document":"wk-form4_1759350029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000024/wk-form4_1759350029.xml","form_type":"4"}},{"id":1030390,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-30T20:24:25.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":false,"shares":13688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal installments beginning on February 24, 2018"}],"balance_after":148812,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":13688},"source":{"system":"sec-edgar","filing":"0001539937-25-000022","document":"wk-form4_1759263862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000022/wk-form4_1759263862.xml","form_type":"4"}},{"id":1030389,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-30T20:24:25.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":10235,"price":48.02,"value":491484.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.14. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1144336,"source":{"system":"sec-edgar","filing":"0001539937-25-000022","document":"wk-form4_1759263862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000022/wk-form4_1759263862.xml","form_type":"4"}},{"id":1030388,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-30T20:24:25.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":true,"shares":13688,"price":25.3,"value":346306.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1154571,"source":{"system":"sec-edgar","filing":"0001539937-25-000022","document":"wk-form4_1759263862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000022/wk-form4_1759263862.xml","form_type":"4"}},{"id":1032883,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-24T20:14:18.000Z","date":"2025-09-23","kind":"exercise","planned":true,"acquired":false,"shares":47940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":47940},"source":{"system":"sec-edgar","filing":"0001539937-25-000020","document":"wk-form4_1758744856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000020/wk-form4_1758744856.xml","form_type":"4"}},{"id":1032882,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-24T20:14:18.000Z","date":"2025-09-23","kind":"sale","planned":true,"acquired":false,"shares":29513,"price":47.23,"value":1393898.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.55. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1140883,"source":{"system":"sec-edgar","filing":"0001539937-25-000020","document":"wk-form4_1758744856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000020/wk-form4_1758744856.xml","form_type":"4"}},{"id":1032881,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-24T20:14:18.000Z","date":"2025-09-23","kind":"exercise","planned":true,"acquired":true,"shares":47940,"price":12.98,"value":622261.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1170396,"source":{"system":"sec-edgar","filing":"0001539937-25-000020","document":"wk-form4_1758744856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000020/wk-form4_1758744856.xml","form_type":"4"}},{"id":1033629,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-23T20:22:02.000Z","date":"2025-09-22","kind":"exercise","planned":true,"acquired":false,"shares":27060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":47940,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":27060},"source":{"system":"sec-edgar","filing":"0001539937-25-000018","document":"wk-form4_1758658919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000018/wk-form4_1758658919.xml","form_type":"4"}},{"id":1033628,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-23T20:22:02.000Z","date":"2025-09-22","kind":"sale","planned":true,"acquired":false,"shares":16587,"price":47.02,"value":779920.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.08. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1122456,"source":{"system":"sec-edgar","filing":"0001539937-25-000018","document":"wk-form4_1758658919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000018/wk-form4_1758658919.xml","form_type":"4"}},{"id":1033627,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-23T20:22:02.000Z","date":"2025-09-22","kind":"exercise","planned":true,"acquired":true,"shares":27060,"price":12.98,"value":351238.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1139043,"source":{"system":"sec-edgar","filing":"0001539937-25-000018","document":"wk-form4_1758658919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000018/wk-form4_1758658919.xml","form_type":"4"}},{"id":1041297,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Units","published_at":"2025-09-12T20:05:53.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":19320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":19320,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":19320},"source":{"system":"sec-edgar","filing":"0001539937-25-000016","document":"wk-form4_1757707550.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000016/wk-form4_1757707550.xml","form_type":"4"}},{"id":1041296,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2025-09-12T20:05:53.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on April 30, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on April 30, 2021."}],"balance_after":20000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001539937-25-000016","document":"wk-form4_1757707550.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000016/wk-form4_1757707550.xml","form_type":"4"}},{"id":1044643,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-09T20:21:18.000Z","date":"2025-09-08","kind":"exercise","planned":true,"acquired":false,"shares":8074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal installments beginning on February 24, 2018"}],"balance_after":162500,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":8074},"source":{"system":"sec-edgar","filing":"0001539937-25-000014","document":"wk-form4_1757449275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000014/wk-form4_1757449275.xml","form_type":"4"}},{"id":1044642,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-09T20:21:18.000Z","date":"2025-09-08","kind":"sale","planned":true,"acquired":false,"shares":6322,"price":46.29,"value":292645.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.40. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1111983,"source":{"system":"sec-edgar","filing":"0001539937-25-000014","document":"wk-form4_1757449275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000014/wk-form4_1757449275.xml","form_type":"4"}},{"id":1044641,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-09T20:21:18.000Z","date":"2025-09-08","kind":"exercise","planned":true,"acquired":true,"shares":8074,"price":25.3,"value":204272.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1118305,"source":{"system":"sec-edgar","filing":"0001539937-25-000014","document":"wk-form4_1757449275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000014/wk-form4_1757449275.xml","form_type":"4"}},{"id":1045679,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-09-08T20:31:16.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":false,"shares":73176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal installments beginning on February 24, 2018."}],"balance_after":170574,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":73176},"source":{"system":"sec-edgar","filing":"0001539937-25-000012","document":"wk-form4_1757363472.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000012/wk-form4_1757363472.xml","form_type":"4"}},{"id":1045678,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-08T20:31:16.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":55578,"price":46.01,"value":2557143.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.09. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1110231,"source":{"system":"sec-edgar","filing":"0001539937-25-000012","document":"wk-form4_1757363472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000012/wk-form4_1757363472.xml","form_type":"4"}},{"id":1045677,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-09-08T20:31:16.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":true,"shares":73176,"price":25.3,"value":1851352.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1165809,"source":{"system":"sec-edgar","filing":"0001539937-25-000012","document":"wk-form4_1757363472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000012/wk-form4_1757363472.xml","form_type":"4"}},{"id":1052684,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-29T20:05:45.000Z","date":"2025-08-28","kind":"exercise","planned":true,"acquired":false,"shares":38779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":75000,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":38779},"source":{"system":"sec-edgar","filing":"0001539937-25-000010","document":"wk-form4_1756497941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000010/wk-form4_1756497941.xml","form_type":"4"}},{"id":1052683,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-29T20:05:45.000Z","date":"2025-08-27","kind":"exercise","planned":true,"acquired":false,"shares":17195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":113779,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":17195},"source":{"system":"sec-edgar","filing":"0001539937-25-000010","document":"wk-form4_1756497941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000010/wk-form4_1756497941.xml","form_type":"4"}},{"id":1052682,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-29T20:05:45.000Z","date":"2025-08-28","kind":"sale","planned":true,"acquired":false,"shares":24150,"price":45.12,"value":1089648.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.26. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1092633,"source":{"system":"sec-edgar","filing":"0001539937-25-000010","document":"wk-form4_1756497941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000010/wk-form4_1756497941.xml","form_type":"4"}},{"id":1052681,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-29T20:05:45.000Z","date":"2025-08-28","kind":"exercise","planned":true,"acquired":true,"shares":38779,"price":12.98,"value":503351.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1116783,"source":{"system":"sec-edgar","filing":"0001539937-25-000010","document":"wk-form4_1756497941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000010/wk-form4_1756497941.xml","form_type":"4"}},{"id":1052680,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-29T20:05:45.000Z","date":"2025-08-27","kind":"sale","planned":true,"acquired":false,"shares":10650,"price":45.05,"value":479782.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.10. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1078004,"source":{"system":"sec-edgar","filing":"0001539937-25-000010","document":"wk-form4_1756497941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000010/wk-form4_1756497941.xml","form_type":"4"}},{"id":1052679,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-29T20:05:45.000Z","date":"2025-08-27","kind":"exercise","planned":true,"acquired":true,"shares":17195,"price":12.98,"value":223191.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1088654,"source":{"system":"sec-edgar","filing":"0001539937-25-000010","document":"wk-form4_1756497941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000010/wk-form4_1756497941.xml","form_type":"4"}},{"id":1054390,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-27T20:56:07.000Z","date":"2025-08-25","kind":"exercise","planned":true,"acquired":false,"shares":1611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":130974,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":1611},"source":{"system":"sec-edgar","filing":"0001539937-25-000008","document":"wk-form4_1756328164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000008/wk-form4_1756328164.xml","form_type":"4"}},{"id":1054389,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-27T20:56:07.000Z","date":"2025-08-25","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":45,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.01. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1071459,"source":{"system":"sec-edgar","filing":"0001539937-25-000008","document":"wk-form4_1756328164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000008/wk-form4_1756328164.xml","form_type":"4"}},{"id":1054388,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-27T20:56:07.000Z","date":"2025-08-25","kind":"exercise","planned":true,"acquired":true,"shares":1611,"price":12.98,"value":20910.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1072459,"source":{"system":"sec-edgar","filing":"0001539937-25-000008","document":"wk-form4_1756328164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000008/wk-form4_1756328164.xml","form_type":"4"}},{"id":1055498,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-26T20:08:54.000Z","date":"2025-08-22","kind":"exercise","planned":true,"acquired":false,"shares":2415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":132585,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":2415},"source":{"system":"sec-edgar","filing":"0001539937-25-000006","document":"wk-form4_1756238931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000006/wk-form4_1756238931.xml","form_type":"4"}},{"id":1055497,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-26T20:08:54.000Z","date":"2025-08-22","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":45,"value":67500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.01. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1070848,"source":{"system":"sec-edgar","filing":"0001539937-25-000006","document":"wk-form4_1756238931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000006/wk-form4_1756238931.xml","form_type":"4"}},{"id":1055496,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-26T20:08:54.000Z","date":"2025-08-22","kind":"exercise","planned":true,"acquired":true,"shares":2415,"price":12.98,"value":31346.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted November 14, 2024."}],"balance_after":1072348,"source":{"system":"sec-edgar","filing":"0001539937-25-000006","document":"wk-form4_1756238931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000153993725000006/wk-form4_1756238931.xml","form_type":"4"}},{"id":1071201,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":false,"shares":81250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in four equal installments beginning on February 24, 2018"}],"balance_after":243750,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":81250},"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071200,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":135000,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071199,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal installments beginning on March 1, 2017."}],"balance_after":195000,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071198,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":63500,"price":43.12,"value":2738120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.56. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1069933,"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071197,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":true,"shares":81250,"price":25.3,"value":2055625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022."}],"balance_after":1133433,"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071196,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":38000,"price":42,"value":1596000.0,"ownership":{"direct":true},"balance_after":1052183,"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071195,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":12.98,"value":778800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022."}],"balance_after":1090183,"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071194,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"sale","planned":true,"acquired":false,"shares":38500,"price":40.24,"value":1549240.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.70. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":1030183,"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1071193,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-08-08T20:40:02.000Z","date":"2025-08-06","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":12.98,"value":778800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2022."}],"balance_after":1068683,"source":{"system":"sec-edgar","filing":"0001628280-25-039302","document":"wk-form4_1754685598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025039302/wk-form4_1754685598.xml","form_type":"4"}},{"id":1103683,"issuer":{"id":6792,"kind":"organization","name":"COGNITION THERAPEUTICS INC"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T23:22:07.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date."}],"balance_after":48500,"source":{"system":"sec-edgar","filing":"0001062993-25-012082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455365/000106299325012082/form4.xml","form_type":"4"}},{"id":1121267,"issuer":{"id":74456,"kind":"organization","name":"scPharmaceuticals Inc.","symbol":"SCPH"},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T16:45:20.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in full upon the earlier of (i) June 03, 2026, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":30000,"derivative":{"exercise_price":3.85,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-25-082429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604950/000095017025082429/ownership.xml","form_type":"4"}},{"id":1179055,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-04-03T20:27:28.000Z","date":"2025-04-02","kind":"other","planned":false,"acquired":false,"shares":16850,"ownership":{"direct":false,"nature":"By the KBT Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is filing this Form 4 to reflect the fact that 16,850 shares were transferred from the KBT Trust to the Reporting Person on April 2, 2025 without consideration and are now owned directly."}],"balance_after":1005600,"source":{"system":"sec-edgar","filing":"0001628280-25-016516","document":"wk-form4_1743712039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025016516/wk-form4_1743712039.xml","form_type":"4"}},{"id":1179054,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-04-03T20:27:28.000Z","date":"2025-04-02","kind":"other","planned":false,"acquired":true,"shares":16850,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person is filing this Form 4 to reflect the fact that 16,850 shares were transferred from the KBT Trust to the Reporting Person on April 2, 2025 without consideration and are now owned directly."}],"balance_after":1008683,"source":{"system":"sec-edgar","filing":"0001628280-25-016516","document":"wk-form4_1743712039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025016516/wk-form4_1743712039.xml","form_type":"4"}},{"id":1211778,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2025-03-11T20:17:35.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001628280-25-012005","document":"wk-form4_1741724247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025012005/wk-form4_1741724247.xml","form_type":"4"}},{"id":1211777,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-03-11T20:17:35.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":16805,"price":32.06,"value":538768.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":991833,"source":{"system":"sec-edgar","filing":"0001628280-25-012005","document":"wk-form4_1741724247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025012005/wk-form4_1741724247.xml","form_type":"4"}},{"id":1211776,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-03-11T20:17:35.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023."}],"balance_after":1008638,"source":{"system":"sec-edgar","filing":"0001628280-25-012005","document":"wk-form4_1741724247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025012005/wk-form4_1741724247.xml","form_type":"4"}},{"id":1217010,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Units","published_at":"2025-03-07T21:40:30.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001628280-25-011338","document":"wk-form4_1741383624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025011338/wk-form4_1741383624.xml","form_type":"4"}},{"id":1217009,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-03-07T21:40:30.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":18581,"price":39.11,"value":726702.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":973638,"source":{"system":"sec-edgar","filing":"0001628280-25-011338","document":"wk-form4_1741383624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025011338/wk-form4_1741383624.xml","form_type":"4"}},{"id":1217008,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2025-03-07T21:40:30.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 17, 2025."}],"balance_after":992219,"source":{"system":"sec-edgar","filing":"0001628280-25-011338","document":"wk-form4_1741383624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025011338/wk-form4_1741383624.xml","form_type":"4"}},{"id":1227125,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2025-03-04T21:21:31.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023."}],"balance_after":35000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001628280-25-009875","document":"wk-form4_1741123284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025009875/wk-form4_1741123284.xml","form_type":"4"}},{"id":1252451,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-21T21:42:00.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":331660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 19, 2026."}],"balance_after":331660,"derivative":{"exercise_price":34.59,"expiration_date":"2035-02-20","underlying":"Common Stock","underlying_shares":331660},"source":{"system":"sec-edgar","filing":"0001628280-25-007147","document":"wk-form4_1740174115.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025007147/wk-form4_1740174115.xml","form_type":"4"}},{"id":1259000,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Units","published_at":"2025-02-19T21:54:01.000Z","date":"2025-02-17","kind":"grant","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":38640,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001628280-25-006420","document":"wk-form4_1740002035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025006420/wk-form4_1740002035.xml","form_type":"4"}},{"id":1320341,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2024-12-30T21:08:06.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001628280-24-052573","document":"wk-form4_1735592879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052573/wk-form4_1735592879.xml","form_type":"4"}},{"id":1320340,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2024-12-30T21:08:06.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":false,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001628280-24-052573","document":"wk-form4_1735592879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052573/wk-form4_1735592879.xml","form_type":"4"}},{"id":1320339,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-12-30T21:08:06.000Z","date":"2024-12-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":6666,"price":35.59,"value":237242.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":953579,"source":{"system":"sec-edgar","filing":"0001628280-24-052573","document":"wk-form4_1735592879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052573/wk-form4_1735592879.xml","form_type":"4"}},{"id":1320338,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-12-30T21:08:06.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023."}],"balance_after":960245,"source":{"system":"sec-edgar","filing":"0001628280-24-052573","document":"wk-form4_1735592879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052573/wk-form4_1735592879.xml","form_type":"4"}},{"id":1320337,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-12-30T21:08:06.000Z","date":"2024-12-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":18567,"price":35.59,"value":660799.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":946245,"source":{"system":"sec-edgar","filing":"0001628280-24-052573","document":"wk-form4_1735592879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052573/wk-form4_1735592879.xml","form_type":"4"}},{"id":1320336,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-12-30T21:08:06.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024."}],"balance_after":964812,"source":{"system":"sec-edgar","filing":"0001628280-24-052573","document":"wk-form4_1735592879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052573/wk-form4_1735592879.xml","form_type":"4"}},{"id":1321515,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2024-12-26T13:42:05.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":38640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":38640,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38640},"source":{"system":"sec-edgar","filing":"0001628280-24-052397","document":"wk-form4_1735220518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052397/wk-form4_1735220518.xml","form_type":"4"}},{"id":1321514,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Performance Share Unit","published_at":"2024-12-26T13:42:05.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."}],"balance_after":14000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001628280-24-052397","document":"wk-form4_1735220518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024052397/wk-form4_1735220518.xml","form_type":"4"}},{"id":1368509,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-12T21:11:32.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal installments beginning on March 3, 2016."}],"balance_after":0,"derivative":{"exercise_price":9.13,"exercise_date":"2016-03-03","expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001628280-24-047142","document":"wk-form4_1731445884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024047142/wk-form4_1731445884.xml","form_type":"4"}},{"id":1368508,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23273,"kind":"person","name":"Khattar Jack A.","position":1,"cik":"0001539937","reported_name":"Khattar Jack A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-11-12T21:11:32.000Z","date":"2024-11-08","kind":"sale","planned":false,"acquired":false,"shares":125000,"price":36.29,"value":4536250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.87 to $36.66. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":926172,"source":{"system":"sec-edgar","filing":"0001628280-24-047142","document":"wk-form4_1731445884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828024047142/wk-form4_1731445884.xml","form_type":"4"}}],"next_cursor":"2024-11-12T21:11:32.000000Z,1368508"}